Main menu

Oxford Nanopore supports COVID-19 pandemic: epidemiology and research


Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pandemic.  This includes rapid sequencing of the novel coronavirus SARS-CoV-2 – the virus that causes COVID-19, as well as approaches that characterise a broader range of pathogens in a sample.

A large number of scientists, from large centralised labs to smaller decentralised ones, are using nanopore sequencing to support rapid sharing of SARS-CoV-2 sequence data.  Rapid data sharing has been key to the public health response, and researchers all over the world have been fast to share the genomes they have sequenced on public databases such as GISAID, GenBank or elsewhere.

As numbers of cases increased, laboratories have built capacity to sequence larger numbers of the genomes, typically progressing from using the MinION device to the GridION device for sequencing. Thousands of genomes sequenced using nanopore technology are now available in public databases.

Due to the extensive amount of work in this area, we have created a COVID-19 mini-site, that includes: extensive research and epidemiology performed by researchers in the nanopore community and guidance on how to use nanopore sequencing

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag